Even on the market's worst days, buyout news and other short-term forces can send individual stocks up by 10%, 25%, even 50%.
For example, shares of Starent Networks jumped 17% when it was announced that Cisco Systems
But beyond less-predictable events like that one are stocks with fundamentally compelling reasons for recent momentum. The trick is to find those stocks. That's where Motley Fool CAPS comes in.
The story behind the story
CAPS is no crowd of lemmings. Its best-performing members' opinions do more to shape each company's rating than the picks of their poorer-performing peers. Let's use the collective wisdom of more than 140,000 CAPS members to filter out the noise and find companies offering strong momentum.
We'll use CAPS' handy stock screening tool to quickly zero in on companies with a stock price increase of at least 25% in the past four weeks, a market cap of greater than $100 million, and a beta of less than 3. Below is a sample of stocks that our screen returned. If you'd like, run this screen yourself -- just keep in mind that results may change as the market does.
Company |
CAPS Rating
|
4-Week |
---|---|---|
KV Pharmaceutical |
***** |
47.1% |
Focus Media |
***** |
37.9% |
Headwaters |
**** |
28.7% |
Alpha Pro Tech |
** |
28.6% |
American Greetings |
* |
48.9% |
Source: Motley Fool CAPS. Price return from Sept. 18 through Oct. 16.
Focus Media
It looks like digital advertising company Focus Media will end up keeping operations that generate more than half its revenue and a large chunk of its profits. SINA's
Alpha Pro Tech
Naturally, the swine flu frenzy draws attention to vaccine producers like Novavax
Alpha Pro Tech's sales increased 63% in the second quarter, helped by record quarterly sales in the building supply business. The company sees growth opportunities in that business, which will help when the swine flu commotion fades. But the micro-cap company has a relatively small following in CAPS and earns just a two-star rating. Today, 37 of the 41 CAPS members rating Alpha Pro Tech expect it to beat the broader market.
And you?
What's your story? Whether you buy the tale of a stock that's soaring or souring, your own research is more important than collective opinions. But these collective opinions can make your due diligence a whole lot easier.
Add your take on these or any of the 5,300 stocks that our 140,000-plus members have covered in Motley Fool CAPS. It's totally free to be a part of the community, and the payback is more than worth it.